Drug Repurposing Flubendazole to Suppress Tumorigenicity via PCSK9-dependent Inhibition and Potentiate Lenvatinib Therapy for Hepatocellular Carcinoma
Wenjiao Jin, Junming Yu, Yang Su, Hechun Lin, Tengfei Liu, Jing Chen, Chao Ge, Fangyu Zhao, Qin Geng, Lin Mao, Shuqing Jiang, Ying Cui, Taoyang Chen, Guo‐Ping Jiang, Jinjun Li, Chunxiao Miao, Xiuying Xiao, Hong Li
Abstract
. These findings reveal the therapeutic potential of flubendazole against HCC and provide clues on new repurposed drugs and targets for cancer treatment.
Topics & Concepts
PharmacologyIn vivoCancer researchHepatocellular carcinomaMedicineBiologyBiotechnologyCancer Mechanisms and TherapyHedgehog Signaling Pathway StudiesEpigenetics and DNA Methylation